ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 84 filers reported holding ITEOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,373 | -24.8% | 7,066 | -9.1% | 0.05% | -23.0% |
| Q2 2023 | $102,915 | +58.1% | 7,773 | +62.5% | 0.06% | +69.4% |
| Q1 2023 | $65,083 | -49.7% | 4,782 | -27.8% | 0.04% | -47.1% |
| Q4 2022 | $129,289 | +16.5% | 6,620 | +13.6% | 0.07% | +54.5% |
| Q3 2022 | $111,000 | -6.7% | 5,828 | +0.7% | 0.04% | 0.0% |
| Q2 2022 | $119,000 | -11.2% | 5,790 | +39.1% | 0.04% | -26.7% |
| Q1 2022 | $134,000 | -34.6% | 4,161 | -5.7% | 0.06% | -22.1% |
| Q4 2021 | $205,000 | -1.9% | 4,412 | -42.9% | 0.08% | -16.3% |
| Q3 2021 | $209,000 | 0.0% | 7,731 | -5.0% | 0.09% | +7.0% |
| Q2 2021 | $209,000 | -39.4% | 8,134 | -19.4% | 0.09% | -41.1% |
| Q1 2021 | $345,000 | +3.0% | 10,092 | +1.8% | 0.15% | +5.0% |
| Q4 2020 | $335,000 | – | 9,916 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |